Browse EX-10 agreements

**JATT III Acquisition Corp  **

153 Central Avenue

C/O 56

Westfield, NJ 07091

[●] , 2026

JATT Ventures III L.P.

153 Central Avenue

C/O 56

Westfield, NJ 07091 

Re:	Administrative Services and Indemnification Agreement

Ladies and Gentlemen:

This letter agreement (this “Agreement”) by and between JATT III Acquisition Corp (the “Company”) and JATT Ventures III L.P. (the “Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed on the Nasdaq Capital Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination (“Business Combination”) or the Company’s liquidation (in each case as described in the Registr

…

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2026, is made and entered into by and between JATT III Acquisition Corp, a Cayman Islands exempted company (the “Company”), JATT Ventures III L.P., a Cayman Islands exempted limited partnership (the “Sponsor”) and each of the undersigned parties listed on the signature page hereto under “Holders” (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).

RECITALS

** **

WHEREAS, the Company has 1,725,000 ordinary shares (“Founder Shares”) of the Company, par value $0.0001 per share (the “Ordinary Shares”), issued and outstanding, up to 225,000 of which will be surrendered to the Company for no consideration depending on the extent to which the underwriters of the Company’s initial public offering exercise their over-allotment option;

** **

…

PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT

** **

THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT, dated as of [●], 2026, (as it may from time to time be amended, this “Agreement”), is entered into by and between JATT III Acquisition Corp, a Cayman Islands exempted company (the “Company”), and JATT Ventures III L.P., a Cayman Islands exempted limited partnership (the “Purchaser”).

WHEREAS, the Company intends to consummate an initial public offering (the “Public Offering”) of shares of the Company’s Ordinary Shares, par value $0.0001 per share (the “Shares”). The Purchaser has agreed to purchase an aggregate of 225,000 Shares (or 234,000 in the aggregate if the over-allotment option in connection with the Public Offering is exercised in full) (the “Private Placement Shares”).

…

SECURITIES SUBSCRIPTION AGREEMENT

JATT III Acquisition Corp

RE: Securities Subscription Agreement

Ladies and Gentlemen:

This agreement (the “Agreement”) is entered into as of June 9, 2026 by and between JATT Ventures III Ltd, an exempted company incorporated in the Cayman Islands with limited liability, acting on behalf of JATT Ventures III L.P. (the “Subscriber” or “you”) as the general partner of the Subscriber, and JATT III Acquisition Corp, an exempted company incorporated in the Cayman Islands with limited liability (the “Company,” “we” or “us”). Pursuant to the terms hereof, the Company hereby accepts the offer the Subscriber has made to purchase 2,156,250 ordinary shares, $0.0001 par value per share (the “Shares”), up to 281,250 of which are subject to forfeiture by you if the underwriters of the initial public offering (“IPO”) of ordinary shares of the Company, do not fully exercise their over-allotment option (the “Over-allotment Option”). The Company and the Subscriber’s agreements regarding such Shares are as follows:

1. Purchase of Securities.

…

*** ***

Execution Version

** **

***THIRD ***AMENDMENT TO CREDIT AGREEMENT

THIS THIRD AMENDMENT TO CREDIT AGREEMENT (“Agreement”) is entered into as of August 24, 2024 (“Third Amendment Effective Date”) by and among IONETIX CORPORATION, a Delaware corporation (“Borrower”), IONETIX ALPHA CORPORATION, a Delaware corporation (“Guarantor”, and together with the borrower, the “Loan Parties”), the Lenders (as defined in the Credit Agreement (as defined herein)), SHAMROCK IONETIX, LLC, as administrative agent (“Administrative Agent”) and as collateral agent (“Collateral Agent”) for the Lenders (Administrative Agent and Collateral Agent, collectively referred to herein as “Agents” and individually, each as an “Agent”).

W I T N E S S E T H:

…

MEDICAL OFFICE LEASE

THIS MEDICAL OFFICE LEASE (this "Lease") is executed, on July 20, 2017, but deemed to be effective on July 1, 2015 (the "Effective Date") by and between **UNIVERSITY OF KANSAS HOSPITAL AUTHORITY, **a public body corporate and independent instrumentality of the State of Kansas ("Landlord"), and **GLOBAL ISOTOPES, LLC, **an Illinois limited liability company, which transacts business under the assumed name of ZEVACOR MOLECULAR ("Tenant").

RECITALS:

WHEREAS, Landlord and Tenant have been operating within the Premises (as hereinafter defined) in accordance with the terms of this Lease since the Effective Date;

WHEREAS, Landlord and Tenant failed to execute this Lease on July 1, 2015, but nonetheless operated in compliance with the terms set forth herein and now wish to fully execute the Lease to properly memorialize the same.

WITNESSETH THAT:

In consideration of the terms, covenants and conditions which are contained and expressed in this Lease, Landlord and Tenant agree as follows:

ARTICLE I.

LEASED PREMISES

…

SUBLEASE AGREEMENT

THIS SUBLEASE AGREEMENT (“this Sublease”) is made and entered by and between DESERT IMAGING SERVICES L.P. (the “Sublessor”) and IONETIX CORPORATION (the “Sublessee”).

WHEREAS, Jeken Property, L.P. (the “Landlord”) and Sublessor entered into that certain First Amended and Restated Lease Agreement dated November 1, 2019 (the “Lease”), relating to leased premises consisting of the property described on Exhibit “A”, attached hereto and incorporated herein, located at 7812 Gateway East, El Paso, Texas 79915 (the “Leased Premises”); and

WHEREAS, Sublessee desires to sublease from Sublessor that portion of the Leased Premises consisting of a vault, which is described on Exhibit “B”, attached hereto and incorporated herein (the “Subleased Premises”), and Sublessor has agreed to sublease the Subleased Premises to Sublessee on the terms and conditions set forth herein.

…

Execution Version

CREDIT AGREEMENT

dated as of

February 24, 2023

among

IONETIX CORPORATION,
as Borrower,

THE LENDERS PARTY HERETO,

SHAMROCK IONETIX, LLC,
as Administrative Agent and Collateral Agent,

and

THE WARRANT INVESTORS PARTY HERETO

Table of Contents

		Page
ARTICLE I Definitions		1

…

***FIRST ***AMENDMENT TO CREDIT AGREEMENT

THIS FIRST AMENDMENT TO CREDIT AGREEMENT (“Agreement”) is entered into as of December 30, 2023 (“First Amendment Effective Date”) by and among IONETIX CORPORATION, a Delaware corporation (“Borrower”), the Lenders (as defined in the Credit Agreement (as defined herein)), SHAMROCK IONETIX, LLC, as administrative agent (“Administrative Agent”) and as collateral agent (“Collateral Agent”).

W I T N E S S E T H:

WHEREAS, Administrative Agent, Collateral Agent, Lenders and Borrower are parties to that certain Credit Agreement dated as of February 24, 2023 (as amended, restated, supplemented or modified from time to time, the Credit Agreement as amended by this Agreement is referred to herein as the “Credit Agreement”); unless otherwise defined herein, capitalized terms used herein that are not otherwise defined herein shall have the respective meanings assigned to such terms in the Credit Agreement);

…

EXECUTION VERSION

FIFTH AMENDMENT TO CREDIT AGREEMENT

THIS FIFTH AMENDMENT TO CREDIT AGREEMENT (“Agreement”) is entered into as of August 19, 2025 (“Fifth Amendment Effective Date”) by and among IONETIX CORPORATION, a Delaware corporation (“Borrower”), IONETIX ALPHA CORPORATION, a Delaware corporation (“Guarantor”, and together with the borrower, the “Loan Parties”), the Lenders (as defined in the Credit Agreement (as defined herein)), SHAMROCK IONETIX, LLC, as administrative agent (“Administrative Agent”) and as collateral agent (“Collateral Agent”) for the Lenders (Administrative Agent and Collateral Agent, collectively referred to herein as “Agents” and individually, each as an “Agent”).

W I T N E S S E T H:

…

EXECUTION

IONETIX CORPORATION

** **

CONVERTIBLE NOTE PURCHASE AGREEMENT

This Convertible Note Purchase Agreement (the “Purchase Agreement”), effective as of July 22, 2024 (the “Effective Date”), is entered into by and among Ionetix Corporation, a Delaware corporation (the “Company”), and Eli Lilly and Company, an Indiana corporation (“Purchaser”). Each of Company and the Purchaser may be referred to herein as a “Party” and, collectively, as the “Parties.”

WHEREAS, the Company desires to enter into this Purchase Agreement with the Purchaser and issue a convertible promissory note in substantially the form attached hereto as Exhibit A (the “Note”); and

WHEREAS, the Purchaser desires to enter into this Purchase Agreement to acquire the Note on the terms and conditions set forth herein.

NOW, THEREFORE, in consideration of the foregoing, and the representations, warranties, covenants and conditions set forth below, the Company and the Purchaser, intending to be legally bound, hereby agree as follows:

…

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***],
HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE
REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

Relating to AlfaRim Medical B.V.

June 13, 2025

Table of Contents

Clause			Page
1	DEFINITIONS AND INTERPRETATIONS		1
2	PURPOSE OF THE AGREEMENT		1
3	TRANSFER OF MATERIAL		2
4	OWNERSHIP AND IP RIGHTS		3
5	USE RESTRICTIONS		4
6	IONETIX OBLIGATIONS		5
7	MUTUAL PARTY OBLIGATIONS		7
8	CONSERVATION		7

…